Library
Bromoketamine
Bromoketamine is classified as Dissociative anesthetic. It belongs to the Arylcyclohexylamine (ketamine analogue) chemical class.
Also known as: BDCK, 2‑BDCK, 2‑BrDCK, 2‑bromodeschloroketamine, Bromo‑DCK
Classification
- Chemical: Arylcyclohexylamine
- Psychoactive: Dissociative
Effects
- Pain Relief
- Somatic Lightness
- Incoordination
- Impaired Balance
- Nystagmus
- Numbness
- Disembodiment
- Euphoria
- Emotional Warmth
- Language Impairment
- Impaired Memory Formation
- Disconnection
- Closed Eye Visuals
- Open Eye Visuals
- Warping
- Auditory Distortion
- Double Vision
- Visual Disconnection
Routes of Administration
Insufflated
Dosage
- Heavy: 250+ (↑ nasal damage risk) mg
- Light: 40–90 mg
- Common: 90–160 mg
- Strong: 160–250 mg
- Threshold: 20–40 mg
Duration
- Onset: 0.08-0.25 h
- Peak: 0.5-1 h
- Offset: 1-1.8 h
- After Effects: 1.8-3 h
- Total Duration: 1-2.5 h
Intramuscular
Dosage
- Heavy: 1.2+ mg/kg
- Light: 0.5 mg/kg
- Common: 0.7–1.0 mg/kg
- Strong: 1.0–1.2 mg/kg
- Threshold: 0.3 mg/kg
Duration
- Onset: 0.03-0.08 h
- Peak: 0.5-1 h
- Offset: 1-2 h
- After Effects: 2-4 h
- Total Duration: 1.5-3 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
No external data sources listed for this substance yet.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
